COMPANY
AMGEN CANADA INC
AMGEN CANADA INC: marketing authorisation holder for Carfilzomib, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Carfilzomib | KYPROLIS (DIN 02451034), Marketed Regulator Health Canada |
|---|---|
| Carfilzomib | KYPROLIS (DIN 02459930), Marketed Regulator Health Canada |
| Carfilzomib | KYPROLIS (DIN 02459949), Marketed Regulator Health Canada |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.